Atlas Trials

Evaluation of Synthetic Thyrotropin Releasing Hormone (TRH) as a Treatment for Cancer-related Fatigue

Clinical trial NCT00790296 · TERMINATED

Trial details

NCT number
NCT00790296
Sponsor
UConn Health
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer-related Fatigue
Start date
2006-12-01
Primary completion
2010-02-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.